Business
Archived — This article has been archived. The information may be outdated.
Deepinder Goyal's Temple acquires London longevity clinic
Livemint··27 Aug
Health-tech startup Temple, founded by Deepinder Goyal, has acquired London-based longevity clinic Longevous, whose founders will join full-time, Goyal said. Financial terms were not disclosed. Dr Robert Mohr will become Temple's Chief Medical Officer, and Dr Avi Roy will lead its science team. Temple is a wearable device tracking cerebral blood flow ahead of its planned launch.
Prism
What It Means For You
- Users of Temple's wearable may see improved accuracy in blood-flow tracking once clinical scientists refine the underlying research.
- Longevity-focused patients in London could see Longevous continue operating under new ownership rather than closing down.
- Consumers evaluating wearable health devices get another entrant backed by clinicians rather than only engineers.
What's Happening
- Dr Robert Mohr, a physician with nearly 20 years of clinical experience, moved from emergency medicine to longevity work.
- Dr Avi Roy is an Oxford-trained scientist who previously worked at Oxford's Centre for the Advancement of Sustainable Medical Innovation.
- Goyal said the founders spent months testing Temple's device before the acquisition talks turned serious.
What Temple's Wearable Device Tracks
- Temple is designed to sit on the temple area of the head and continuously track cerebral blood flow and oxygenation.
- Longevous is described as an evidence-based longevity medicine practice, distinct from wellness clinics without clinical backing.
- Goyal said Longevous will continue operating as before, now as part of Temple, with its founders retaining client relationships.
all-news
